HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• Persistent Human Papillomavirus type 16 (HPV-16) infection is crucial for cervical cancer development.
• Viral proteins, such as HPV-16 E5, actively counteract the host immune response to ensure viral persistence.
• HPV-16 E5 is known to down-regulate MHC/HLA class I expression on infected cells.

Purpose of the Study:

• To investigate the functional impact of HPV-16 E5-mediated MHC class I down-regulation on human CD8+ T cell recognition.
• To overcome the challenge of requiring HLA-matched, HPV-specific T cells for studying this interaction.

Main Methods:

• Utilized a heterologous cell/MHC I system.
• Employed mouse cells engineered to express both HPV-16 E5 and HLA-A2.
• Tested recognition by HLA-A2-restricted Cytotoxic T Lymphocytes (CTLs).

Main Results:

• Demonstrated that HPV-16 E5 expression leads to a reduction in HLA-A2 on the cell surface.
• Showed this E5-induced reduction of HLA-A2 significantly impairs the recognition of E5-expressing cells by HPV-specific CD8+ T cells.
• Confirmed the functional consequence of MHC I down-regulation in evading immune surveillance.

Conclusions:

• HPV-16 E5 actively suppresses immune recognition by reducing cell surface HLA-A2.
• This viral immune evasion mechanism contributes to the persistence of HPV infection, a critical factor in cervical carcinogenesis.
• The findings highlight a key pathway through which HPV-16 promotes cancer development by subverting cellular anti-viral immunity.